Atlas Merchant Capital’s Envoy Medical COCH Stock Holding History

Atlas Merchant Capital’s Portfolio COCH Stock Details COCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-555,527	Closed	-$431K	–	3
2025 Q3	$431K	Hold	555,527	–	–	0.19%	3
2025 Q2	$789K	Hold	555,527	–	–	0.24%	4
2025 Q1	$722K	Hold	555,527	–	–	1.81%	8
2024 Q4	$817K	Hold	555,527	–	–	0.73%	12
2024 Q3	$1.81M	Hold	555,527	–	–	1.7%	13
2024 Q2	$1.31M	Sell	555,527 -43,892	-7%	-$163K	0.48%	29
2024 Q1	$2.35M	Sell	599,419 -300,581	-33%	-$880K	0.82%	29
2023 Q4	$1.67M	Hold	900,000	–	–	0.46%	45
2023 Q3	$6.17M	Hold	900,000	–	–	1.26%	16
2023 Q2	$9.22M	Hold	900,000	–	–	1.68%	13
2023 Q1	$9.04M	Hold	900,000	–	–	1.36%	18
2022 Q4	$9.09M	Buy	+900,000	New	+$8.95M	1.46%	14

Other funds holding COCH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return

ACP

Arcus Capital Partners Atlanta, Georgia $278M AUM 14.53% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Atlas Merchant Capital's COCH Position: Q4 2025 in Review

Atlas Merchant Capital sold out of Envoy Medical (COCH) in Q4 2025, closing a stake of 555,527 shares — an estimated $431K sold.

Atlas Merchant Capital first reported a position in COCH in Q4 2022 and held it in 12 quarters. The position peaked at $9.22M in Q2 2023. 27 funds tracked by Wall St. Rank hold COCH as of Q4 2025.

Atlas Merchant Capital reported no remaining Envoy Medical position as of Q4 2025 after selling out during the quarter.
Atlas Merchant Capital sold 555,527 Envoy Medical shares in Q4 2025, an estimated $431K.
Atlas Merchant Capital first reported a position in Envoy Medical in Q4 2022 and held it in 12 quarters.
Atlas Merchant Capital's Envoy Medical position peaked at $9.22M in Q2 2023.
27 funds tracked by Wall St. Rank held Envoy Medical as of Q4 2025.

Based on Atlas Merchant Capital's 13F filing for Q4 2025, filed 13 Feb 2026.